Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐11C]‐2‐(4′‐methylaminophenyl)‐ 6‐hydroxybenzothiazole

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Neurology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.22320PMID 21337603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved detection of active multiple sclerosis lesions: 3D subtraction imaging.

  2010cited by this paper
• Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis.

  2009cited by this paper
• In Vivo Quantification of Myelin Changes in the Vertebrate Nervous System

  2009cited by this paper
• Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias

  2009cited by this paper
• A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.

  2009cited by this paper
• Longitudinal changes in myelin water fraction in two MS patients with active disease.

  2009cited by this paper
• From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases

  2008cited by this paper
• 3D MPRAGE improves classification of cortical lesions in multiple sclerosis

  2008cited by this paper
• Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

  2008cited by this paper
• Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology

  2007cited by this paper
• Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion

  2007cited by this paper
• Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin.

  2007cited by this paper
• Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?

  2007cited by this paper
• Remyelination is extensive in a subset of multiple sclerosis patients.

  2006cited by this paper
• Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.

  2006cited by this paper
• Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology

  2006cited by this paper
• Imaging of CNS myelin by positron-emission tomography.

  2006influential reference
• A Novel Fluorescent Probe That Is Brain Permeable and Selectively Binds to Myelin

  2006cited by this paper
• Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

  2005cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Demyelination increases radial diffusivity in corpus callosum of mouse brain

  2005cited by this paper
• Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients

  2005cited by this paper
• Promoting repair in multiple sclerosis: problems and prospects

  2005cited by this paper
• Detection of Myelination Using a Novel Histological Probe

  2005cited by this paper
• Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function.

  2004cited by this paper
• A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1)

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component

  2003cited by this paper
• Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

  2003cited by this paper
• Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

  2001cited by this paper
• Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis.

  1998cited by this paper
• Three-dimensional Structure of Myelin Basic Protein

  1997cited by this paper
• A high‐resolution three‐dimensional T1‐weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis

  1996cited by this paper
• Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

  1989cited by this paper
• Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype.

  1987cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• Pathways in medulla oblongata of monkeys mediating splanchnic nerve activity. Electrophysiological and anatomical evidence.

  1972cited by this paper

• Advances in multiscale myelin imaging: from classical histology to functional insights.

  2026influential citation
• Regional distribution of an amyloid radiotracer in healthy aged human brain measured by PET with [18F]flutemetamol: a relation with myelin distribution.

  2026cites this paper
• Translational molecular imaging and drug development in multiple sclerosis

  2026cites this paper
• Salivary Gland Uptake on 18F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease

  2026cites this paper
• Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter

  2025cites this paper
• APOE4 carriership status influences [11C]PiB white matter retention in cognitively healthy older adults.

  2025cites this paper
• Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

  2025cites this paper
• Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers

  2025cites this paper
• First evaluation in multiple sclerosis using PET tracer [18F]3F4AP demonstrates heterogeneous binding across lesions

  2025cites this paper
• Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration

  2025cites this paper
• Accelerated aging of white matter in late-life depression: evidence from 18F-flutemetamol PET imaging.

  2025cites this paper
• Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia as a Presentation of a Novel DNMT1 Mutation

  2025cites this paper
• Artificial intelligence in presymptomatic neurological diseases: Bridging normal variation and prodromal signatures.

  2025cites this paper
• Accounting for white matter uptake improves between tracer agreement in amyloid PET

  2025cites this paper
• Validating a minipig model of reversible cerebral demyelination using human diagnostic modalities and electron microscopy

  2024influential citation
• Two decades of [11C]PiB synthesis, 2003-2023: a review.

  2024cites this paper
• Evaluation of myelin content in the spinal cord of patients with multiple sclerosis: A positron emission tomography study.

  2024cites this paper
• The perspectives of neurologists on positron emission tomography utility in multiple sclerosis: A qualitative study.

  2024cites this paper
• Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.

  2024cites this paper
• Traumatic Brain Injury and Alzheimer’s Disease Biomarkers: A Systematic Review of Findings from Amyloid and Tau Positron Emission Tomography

  2024cites this paper
• Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls

  2024influential citation
• Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

  2024cites this paper
• Assessing disease progression and treatment response in progressive multiple sclerosis

  2024cites this paper
• The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair

  2024cites this paper
• Operationalizing the centiloid scale for [18F]florbetapir PET studies on PET/MRI

  2023cites this paper
• [New neuroimaging methods in assessing the activity of neuroinflammation in multiple sclerosis].

  2023cites this paper
• Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

  2023cites this paper
• Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner

  2023cites this paper
• Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography

  2023cites this paper
• The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?

  2023cites this paper
• Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study

  2022cites this paper
• Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

  2022cites this paper
• From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions

  2022cites this paper
• Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis

  2022cites this paper
• Applications of generative adversarial networks in neuroimaging and clinical neuroscience

  2022cites this paper
• Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study

  2022cites this paper
• A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis.

  2022cites this paper
• Hybrid 18F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients

  2022cites this paper
• Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage

  2022cites this paper
• Operationalising the Centiloid Scale for florbetapir PET Studies on PET/MR

  2022cites this paper
• Seeing is believing: Identifying remyelination in the central nervous system.

  2022cites this paper
• Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.

  2022cites this paper
• Promoting and measuring remyelination and neuroprotection in clinical trials of people with multiple sclerosis

  2021cites this paper
• Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease

  2021cites this paper
• Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study.

  2021cites this paper
• Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal

  2021cites this paper
• Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET

  2021cites this paper
• The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis

  2021cites this paper
• Recent advancements in peripheral nerve-specific fluorescent compounds.

  2021cites this paper
• Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis

  2021cites this paper
• 18F- orbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

  2021cites this paper
• Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis

  2021cites this paper
• 18F-florbetapir PET/MRI for quantitatively monitoring myelin loss and recovery in patients with multiple sclerosis: A longitudinal study

  2021cites this paper
• 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

  2021cites this paper
• Longitudinal Association between White Matter Hyperintensities and White Matter Beta-Amyloid Deposition in Cognitively Unimpaired Elderly.

  2021cites this paper
• Positron emission tomography in multiple sclerosis — straight to the target

  2021cites this paper
• Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter

  2021cites this paper
• White Matter Pathology

  2021cites this paper
• Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology.

  2021cites this paper
• MRI QUANTIFICATION OF MULTIPLE SCLEROSIS PATHOLOGY

  2021cites this paper
• Impact of Age on Multiple Sclerosis Disease Activity and Progression

  2020cites this paper
• Evaluation of the potassium channel tracer [18F]3F4AP in rhesus macaques

  2020cites this paper
• Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients

  2020cites this paper
• Myelin positron emission tomography (PET) imaging in multiple sclerosis

  2020cites this paper
• Remyelination in multiple sclerosis: from basic science to clinical translation.

  2020cites this paper
• Reply to “Amyloid Positron Emission Tomography in Multiple Sclerosis: Between Amyloid Deposition and Myelin Damage”

  2020cites this paper
• Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months.

  2020cites this paper
• On the merits of non-invasive myelin imaging in epilepsy, a literature review.

  2020cites this paper
• The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases

  2020cites this paper
• Imaging and therapy in multiple sclerosis

  2020cites this paper
• Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination

  2020cites this paper
• Multimodal analysis using [11C]PiB-PET/MRI for functional evaluation of patients with Alzheimer’s disease

  2020cites this paper
• Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!

  2019cites this paper
• Developing therapeutic strategies to promote myelin repair in multiple sclerosis

  2019cites this paper
• Novel 18F-Labeled Radioligands for Positron Emission Tomography Imaging of Myelination in the Central Nervous System.

  2019cites this paper
• Recent Advances in Live Imaging of Cells of the Oligodendrocyte Lineage.

  2019cites this paper
• Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS

  2019cites this paper
• A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies

  2019cites this paper
• Promoting remyelination in multiple sclerosis

  2019cites this paper
• Ultrahigh field imaging of myelin disease models: Toward specific markers of myelin integrity?

  2019cites this paper
• Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers

  2019cites this paper
• Investigation of white matter PiB uptake as a marker of white matter integrity

  2019cites this paper
• Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB

  2019cites this paper
• Neuroglia Molecular Mechanisms in Psychiatric Disorders

  2019cites this paper
• 18F-florbetapir PET/MRI for quantitatively monitoring demyelination and remyelination in acute disseminated encephalomyelitis

  2019cites this paper
• Predicting PET-derived demyelination from multimodal MRI using sketcher-refiner adversarial training for multiple sclerosis

  2019cites this paper
• Remyélinisation du système nerveux central et sclérose en plaques

  2019cites this paper
• [11C]PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis.

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Increased Pit tsburgh Compound-B Accumulat ion in the Subcort ical White Matter of Alzheimer ' s Disease Brain

  2019cites this paper
• Probing Estrogen Sulfotransferase-Mediated Inflammation with [11C]-PiB in the Living Human Brain

  2019cites this paper
• Clinical implications of myelin regeneration in the central nervous system

  2018cites this paper
• Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders

  2018cites this paper
• An evolutionary approach

  2018cites this paper
• Is the role of amyloid in senile dementia substantial

  2018cites this paper
• A new frontier for amyloid PET imaging: multiple sclerosis

  2018cites this paper
• Topography of 11C-Pittsburgh compound B uptake in Alzheimer’s disease: a voxel-based investigation of cortical and white matter regions

  2018cites this paper
• Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

  2018cites this paper
• Optimizing Longitudinal Amyloid-β PET Measurement: The Challenges of Intensity Normalization

  2018cites this paper
• Imaging Protein Misfolding in the Brain Using β-Sheet Ligands

  2018cites this paper
• Live-cell fluorescence imaging: assessment of thioflavin T uptake in human epidermal carcinoma cells.

  2018cites this paper